Sin Hang Lee, MD
V.
United States
May 15, 2018
$57.1 Million Lyme Disease Lawsuit Filed Against CDC
“Unprecedented” lawsuit claims CDC wrongfully terminated agreement to evaluate guaranteed “no false-positive” DNA based Lyme test utilizing superior technology.
Press Release- May 15, 2018
http://www.dnalymetest.com/images/FINAL_-_Published_CDC_Lawsuit_News_Release_-_Nat_l_Version.pdf
Court Case Document
https://www.dropbox.com/s/zem4v9sceg1v63d/Lee%20CDC%20Complaint%205-15-2018.pdf?dl=0
Attachments
Dr. Sin Hang Lee intends to use the award from the lawsuit to help patients by setting up DNA testing laboratories. He will share his documents with patients and others in order to file additional legal actions.
Milford Molecular Diagnostics Lab Information- Lyme Tests http://www.dnalymetest.com/lymediseasednatesting.html
QUOTE- “…these patients represented undiagnosed cases of Lyme and related borreliosis or persistent infection of Lyme and related borreliosis after standard antibiotic treatments failed to eradicate the causative agents from the infected tissues.” Source
Lyme Disease Test Claim Against CDC Rejected by Federal Circuit
July 7, 2020, 12:01 PM
- Pathologist didn’t show CDC made offer for diagnostic test
- Also failed to show CDC employees had authority to bind agency
A pathologist didn’t adequately allege that the Centers for Disease Control and Prevention breached a contract to develop a Lyme disease diagnosis test, the Federal Circuit affirmed Tuesday.
The U.S. Court of Federal Claims properly dismissed Dr. Sing Hang Lee’s claim that the CDC breached an implied-in-fact contract because he didn’t plausibly allege that the agency made an offer for his test in exchange for the agency’s endorsement, the U.S. Court of Appeals for the Federal Circuit said in a nonprecedential decision.
Lee also didn’t show acceptance of an offer from the CDC because he didn’t adequately allege that he...
To read the full article log in. To learn more about a subscription click here.